Revolution Medicines to Participate in 2nd Annual RAS-Targeted Drug Development Conference
REDWOOD CITY, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused […]
Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
Pivotal Phase 3 clinical trial of oral tebipenem HBr met primary endpoint, demonstrating statistical non-inferiority versus intravenous ertapenem in patients […]
TSX News -
Marathon Gold Reports Additional Exploration Drill Results from the Valentine Gold Project
TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”; TSX: MOZ) is pleased to report […]
REPEAT – Developing Patent Portfolio: Taat Completes Filing of its First U.S. Patent for Beyond Tobacco™ Base Material Refinement Process
In preparation for launching Beyond Tobacco™ cigarettes, which is set to take place in Q4 2020, the Company has completed […]
Blueberries Medical to Webcast Live at VirtualInvestorConferences.com on September 10th
TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE:BBM) (OTCQB: BBRRF) (FRA: 1OA), (the “Company” or “Blueberries“), a […]
BetterLife Pharma Engages Hybrid Financial Ltd.
VANCOUVER, Sept. 08, 2020 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / […]
TSX News -
Recommended Revised and Improved All-Cash Takeover Offer of Cardinal Resources by Shandong Gold
TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX / TSX: CDV) (“Cardinal” or “the Company”) refers to […]
Kitov Announces Dosing of First Patient in Phase 1/2 Clinical Trial of NT219 in Advanced Cancer Patients
TEL AVIV, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) — Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class […]
Medigus: Fortune 500 Multinational Healthcare Corporation’s Adds ScoutCam to its Approved Supplier List
OMER, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and […]
Corbus Pharmaceuticals Announces Topline Results from RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
Topline data showed no significant differences in the primary and secondary endpoints when comparing lenabasum to placebo, both added to background drug […]
